These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 30646343

  • 1. Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia.
    Barmettler S, Ong MS, Farmer JR, Choi H, Walter J.
    JAMA Netw Open; 2018 Nov 02; 1(7):e184169. PubMed ID: 30646343
    [Abstract] [Full Text] [Related]

  • 2. Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients.
    Labrosse R, Barmettler S, Derfalvi B, Blincoe A, Cros G, Lacombe-Barrios J, Barsalou J, Yang N, Alrumayyan N, Sinclair J, Ong MS, Camargo CA, Walter J, Haddad E.
    J Allergy Clin Immunol; 2021 Aug 02; 148(2):523-532.e8. PubMed ID: 33862010
    [Abstract] [Full Text] [Related]

  • 3. Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: a case series.
    Roberts DM, Jones RB, Smith RM, Alberici F, Kumaratne DS, Burns S, Jayne DR.
    J Autoimmun; 2015 Feb 02; 57():24-9. PubMed ID: 25586449
    [Abstract] [Full Text] [Related]

  • 4. Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases.
    Khojah AM, Miller ML, Klein-Gitelman MS, Curran ML, Hans V, Pachman LM, Fuleihan RL.
    Pediatr Rheumatol Online J; 2019 Aug 28; 17(1):61. PubMed ID: 31462263
    [Abstract] [Full Text] [Related]

  • 5. Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections.
    Casulo C, Maragulia J, Zelenetz AD.
    Clin Lymphoma Myeloma Leuk; 2013 Apr 28; 13(2):106-11. PubMed ID: 23276889
    [Abstract] [Full Text] [Related]

  • 6. Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease.
    Roberts DM, Jones RB, Smith RM, Alberici F, Kumaratne DS, Burns S, Jayne DR.
    J Autoimmun; 2015 Feb 28; 57():60-5. PubMed ID: 25556904
    [Abstract] [Full Text] [Related]

  • 7. Predictors of hypogammaglobulinemia and serious infections among patients receiving ocrelizumab or rituximab for treatment of MS and NMOSD.
    Mears V, Jakubecz C, Seeco C, Woodson S, Serra A, Abboud H.
    J Neuroimmunol; 2023 Apr 15; 377():578066. PubMed ID: 36917920
    [Abstract] [Full Text] [Related]

  • 8. Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults.
    McAtee CL, Lubega J, Underbrink K, Curry K, Msaouel P, Barrow M, Muscal E, Lotze T, Srivaths P, Forbes LR, Allen C, Bernhardt MB.
    JAMA Netw Open; 2021 Feb 01; 4(2):e2036321. PubMed ID: 33533931
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease.
    Tieu J, Smith RM, Gopaluni S, Kumararatne DS, McClure M, Manson A, Houghton S, Jayne DRW.
    Front Immunol; 2021 Feb 01; 12():671503. PubMed ID: 34054846
    [Abstract] [Full Text] [Related]

  • 11. Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab.
    Besada E.
    BMC Musculoskelet Disord; 2016 Jan 06; 17():6. PubMed ID: 26738559
    [Abstract] [Full Text] [Related]

  • 12. Incidence of Profound Hypogammaglobulinemia and Infection Rate in Lymphoma Patients Following the Combination of Chemotherapy and Rituximab.
    Filanovsky K, Miller EB, Sigler E, Berrebi A, Shvidel L.
    Recent Pat Anticancer Drug Discov; 2016 Jan 06; 11(2):228-35. PubMed ID: 26825174
    [Abstract] [Full Text] [Related]

  • 13. Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.
    Perriguey M, Maarouf A, Stellmann JP, Rico A, Boutiere C, Demortiere S, Durozard P, Pelletier J, Audoin B.
    Neurol Neuroimmunol Neuroinflamm; 2022 Jan 06; 9(1):. PubMed ID: 34815322
    [Abstract] [Full Text] [Related]

  • 14. Consequences of B-cell-depleting therapy: hypogammaglobulinemia and impaired B-cell reconstitution.
    Sacco KA, Abraham RS.
    Immunotherapy; 2018 Jun 06; 10(8):713-728. PubMed ID: 29569510
    [Abstract] [Full Text] [Related]

  • 15. Hypogammaglobulinemia and bacterial infections following pediatric post-transplant lymphoproliferative disorder in the rituximab era.
    Chiou FK, Beath SV, Patel M, Gupte GL.
    Pediatr Transplant; 2019 Sep 06; 23(6):e13519. PubMed ID: 31209964
    [Abstract] [Full Text] [Related]

  • 16. The association between hypogammaglobulinemia severity and infection risk in rituximab-treated patients with childhood-onset idiopathic nephrotic syndrome.
    Inoki Y, Nishi K, Sato M, Ogura M, Kamei K.
    Pediatr Nephrol; 2023 Feb 06; 38(2):451-460. PubMed ID: 35748947
    [Abstract] [Full Text] [Related]

  • 17. Subcutaneous immunoglobulin in lymphoproliferative disorders and rituximab-related secondary hypogammaglobulinemia: a single-center experience in 61 patients.
    Compagno N, Cinetto F, Semenzato G, Agostini C.
    Haematologica; 2014 Jun 06; 99(6):1101-6. PubMed ID: 24682509
    [Abstract] [Full Text] [Related]

  • 18. Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody-Associated Diseases.
    Avouac A, Maarouf A, Stellmann JP, Rico A, Boutiere C, Demortiere S, Marignier R, Pelletier J, Audoin B.
    Neurol Neuroimmunol Neuroinflamm; 2021 May 06; 8(3):. PubMed ID: 33722933
    [Abstract] [Full Text] [Related]

  • 19. Immunoglobulin serum levels in rituximab-treated patients with steroid-dependent nephrotic syndrome.
    Parmentier C, Delbet JD, Decramer S, Boyer O, Hogan J, Ulinski T.
    Pediatr Nephrol; 2020 Mar 06; 35(3):455-462. PubMed ID: 31705306
    [Abstract] [Full Text] [Related]

  • 20. Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study.
    Wade SD, Kyttaris VC.
    Rheumatol Int; 2021 Jun 06; 41(6):1115-1124. PubMed ID: 33811499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.